Literature DB >> 2242439

Role of vasopressin in cardiovascular and blood pressure regulation.

F M Abboud1, J S Floras, P E Aylward, G B Guo, B N Gupta, P G Schmid.   

Abstract

At low concentrations and in physiologic states vasopressin is a potent antidiuretic hormone. Its cardiovascular effects have been more complex and their role in circulatory adjustments to hypovolemia and hypotension difficult to define with precision. Although recognized as a powerful vasoconstrictor, its pressor effect in intact animals, even at high concentrations, is minimal. The reasons for this blunted pressor response have been explored. This report is a review of previously published work from our laboratories which highlights the direct and indirect vasodilator actions of this hormone in animals and humans. The indirect vasodilator effect is caused by inhibition of sympathetic efferents, and facilitation of the baroreflex through a central action of the hormone and its sensitization of arterial baroreceptors as well as cardiac afferents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242439     DOI: 10.1159/000158801

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  11 in total

1.  V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.

Authors:  Taka-aki Koshimizu; Yoshihisa Nasa; Akito Tanoue; Ryo Oikawa; Yuji Kawahara; Yasushi Kiyono; Tetsuya Adachi; Toshiki Tanaka; Tomoyuki Kuwaki; Toyoki Mori; Satoshi Takeo; Hitoshi Okamura; Gozoh Tsujimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

2.  Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunction.

Authors:  Melissa A Wasilewski; Laurel A Grisanti; Jianliang Song; Rhonda L Carter; Ashley A Repas; Valerie D Myers; Erhe Gao; Walter J Koch; Joseph Y Cheung; Arthur M Feldman; Douglas G Tilley
Journal:  Clin Sci (Lond)       Date:  2016-09-02       Impact factor: 6.124

3.  A comparison between haemodynamic effects of vasopressin analogues.

Authors:  Reza Tabrizchi; Carol Ann Ford
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-27       Impact factor: 3.000

Review 4.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

5.  Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.

Authors:  Andrea Morelli; Monica Rocco; Giorgio Conti; Alessandra Orecchioni; Andrea De Gaetano; Giuliana Cortese; Flaminia Coluzzi; Enrico Vernaglione; Paolo Pelaia; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2003-12-12       Impact factor: 17.440

6.  Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children.

Authors:  Dincer Yildizdas; Hacer Yapicioglu; Umit Celik; Yasar Sertdemir; Emre Alhan
Journal:  Intensive Care Med       Date:  2007-12-19       Impact factor: 17.440

Review 7.  Clinical review: Vasopressin and terlipressin in septic shock patients.

Authors:  Anne Delmas; Marc Leone; Sébastien Rousseau; Jacques Albanèse; Claude Martin
Journal:  Crit Care       Date:  2004-09-09       Impact factor: 9.097

8.  Increased Hepato-Splanchnic Vasoconstriction in Diabetics during Regular Hemodialysis.

Authors:  Werner Ribitsch; Daniel Schneditz; Casper F M Franssen; Gernot Schilcher; Vanessa Stadlbauer; Jörg H Horina; Alexander R Rosenkranz
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

9.  Vasopressin vs Terlipressin in Treatment of Refractory Shock.

Authors:  G Scarpati; O Piazza
Journal:  Transl Med UniSa       Date:  2013-01-04

Review 10.  Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.

Authors:  Cheryl L Holmes; Donald W Landry; John T Granton
Journal:  Crit Care       Date:  2003-06-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.